Tuberculous meningitis: The challenges

Neurology India

Volumn 58, Issue 5, 2010, Pages 716-722

  Murthy, J M K ^a  

^a CARE HOSPITAL   (India)

Author keywords

Antituberculous drugs; elevated intracranial pressure; hydrocephalus; hyponatremia; tuberculoma; tuberculous meningitis; vasculitis

Indexed keywords

1 (6 BROMO 2 METHOXY 3 QUINOLINYL) 4 DIMETHYLAMINO 2 (1 NAPHTHYL) 1 PHENYL 2 BUTANOL; ANTICONVULSIVE AGENT; ANTIPYRETIC AGENT; BENZODIAZEPINE; CORTICOSTEROID; DEXAMETHASONE; DIURETIC AGENT; ETIRACETAM; FLUDROCORTISONE; FOSPHENYTOIN SODIUM; FUROSEMIDE; ISONIAZID; MANNITOL; PHENYTOIN; PYRAZINAMIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; SODIUM CHLORIDE; TUBERCULOSTATIC AGENT; VALPROIC ACID;

ADJUVANT THERAPY; ANTIBIOTIC THERAPY; BRAIN INJURY; BRAIN VENTRICLE PERITONEUM SHUNT; CENTRAL NERVOUS SYSTEM TUBERCULOSIS; CLINICAL PRACTICE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; EARLY DIAGNOSIS; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; FEVER; GLASGOW COMA SCALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCEPHALUS; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INTRACRANIAL HYPERTENSION; LABORATORY DIAGNOSIS; LUNG TUBERCULOSIS; MORTALITY; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; NAUSEA; NEURORADIOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PAPILLEDEMA; PRACTICE GUIDELINE; REVIEW; SEIZURE; TUBERCULOMA; TUBERCULOSIS; TUBERCULOUS MENINGITIS; VASCULITIS;

ANTI-INFECTIVE AGENTS; FEVER; HUMANS; HYPONATREMIA; INTRACRANIAL PRESSURE; SEIZURES; STEROIDS; TOMOGRAPHY, X-RAY COMPUTED; TUBERCULOSIS, MENINGEAL; VASCULITIS;

EID: 78149401485     PISSN: 00283886     EISSN: 19984022     Source Type: Journal    
DOI: 10.4103/0028-3886.72178     Document Type: Review

References (92)

1. Murthy JM. Management of intracranial pressure in tuberculous meningitis. Neurocrit Care 2005;2:306-12.
2. Rock RB, Olin M, Baker CA, Molitor TW, Peterson PK. Central nervous system tuberculosis: Pathogenesis and clinical aspects. Clin Microbiol Rev 2008;21:243-61.
3. Global tuberculosis control: Epidemiology, strategy, financing, WHO report 2009 (publication No. WHO/HMT/TB/2009.411). Geneva: World Health Organization; 2009.
4. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: Estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999;282:677-86.
5. Bishburg E, Sunderam G, Reichman LB, Kapila R. Central nervous system tuberculosis with the acquired immunodeficiency syndrome and its related complex. Ann Intern Med 1986;105:210-3.
6. Donald PR, Schoeman JF. Tuberculous meningitis. N Engl J Med 2004;351:1719-20.
7. Chakraborty AK. Estimating mortality from tuberculous meningitis in a community: Use of available epidemiological parmeters in the Indian context. Ind J Tub 2000;47:9-12.
8. Thwaites GE, Duc Bang N, Huy Dung N, Thi Quy H, Thi Tuong Oanh D, Thi Cam Thoa N, et al. The influence of HIV infection on clinical presentation, response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis 2005;192:2134-41.
9. van der Weert EM, Hartgers NM, Schaaf HS, Eley BS, Pitcher RD, Wieselthaler NA, et al. Comparison of diagnostic criteria of tuberculous meningitis in human immunodeficiency virus-infected and uninfected children. Pediatr Infect Dis J 2006;25:65-9.
10. British Medical Research Council. Streptomycin treatment of tuberculous meningitis. Br Med J 1948;1:582-97.
11. Thwaites GE, Hein TT. Tuberculous meningitis: Many questions, too few answers. Lancet Neurol 2005;4:160-70.
12. Udani PM, Parekh UC, Dastur DK. Neurological and related syndromes in CNS tuberculous meningitis: Clinical features and pathogenesis. J Neurol Sci 1971;14:341-57.
13. van Well GT, Paes BF, Terwee CB, Springer P, Roord JJ, Donald PR, et al. Twenty years of pediatric tuberculous meningitis: A retrospective cohort study in the western cape of South Africa. Pediatrics 2009;123:e1-8.
14. Karstaedt AS, Valtchanova S, Barriere R, Crewe-Brown HH. Tuberculous meningitis in South African urban adults. QJM 1998;91:743-7.
15. Katrak SM, Shembalkar PK, Rijwe SR, Bhandarkar LD. The clinical, radiological and pathological profile of tuberculous meningitis to patients with and without human immunodeficiency virus infection. J Neurol Sci 2000;181:118-26.
16. Whiteman M, Espinoza L, Post MJ, Bell MD, Falcone S. Central nervous system tuberculosis in HIV-infected patients: Clinical and radiographic findings. AJNR Am J Neuroradiol 1995;16:1319-27.
17. Kumar R, Singh SN, Kohli N. A diagnostic rule for tuberculous meningitis. Arch Dis Child 1999;81:221-4.
18. Thwaites GE, Chau TT, Stepniewska K, Phu NH, Chuong LV, Sinh DX, et al. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. Lancet 2002;360:1287-92.
19. Sinner SW, Tunkel AR. Approach to the diagnosis and management of tuberculous meningitis. Curr Infect Dis Rep 2002;2:324-31.
20. Thwaites GE, Chau TT, Farrar JJ. Improving the bacteriological diagnosis of tuberculosis meningitis. J Clin Microbiol 2004;42:378-9.
21. Pai M, Flores LL, Pai N, Hubbard A, Riley LW, Colford JM. Diagnostic accuracy of neucleic acid amplification tests for tuberculous meningitis: A systematic review and meta-analysis. Lancet Infect Dis 2003;3:633-43.
22. Bernaerts A, Vanhoenacker FM, Parizel PM, Van Goethem JW, Van Altena R, Laridon A, et al. Tuberculosis of the central nervous system: Overview of neuroradiological findings. Eur Radiol 2003;13:1876-90.
23. Kumar R, Kohli N, Thavani H, Kumar A, Sharma B. Value of CT scan in the diagnosis of meningitis. Indian Pediatr 1996;33:465-8.
24. Andronikou S, Smith B, Hatherhill M, Douis H, Wilmshurst J. Definitive neuroradiological diagnostic feature of tuberculous meningitis in children. Pediatr Radiol 2004;34:876-85.
25. Offenbacher H, Fazekas F, Schmidt R, Kleinert R, Payer F, Kleinert G, et al. MRI in tuberculous meningoencephalitis: Report of four cases and review of the neurimaging literature. J Neurol 1991;238:340-4.
26. Ranjan P, Kalita J, Misra UK. Serial study of clinical and CT changes in tuberculous meningitis. Neuroradiology 2003;45:277-82.
27. Thwaites GE, Macmullen-Price J, Tran TH, Pham PM, Nguyen TD, Simmons CP, et al. Serial MRI to determine the effect of dexamethasone on the cerebral pathology of tuberculous meningitis: An observational study. Lancet Neurol 2007;6:230-6.
28. Srikanth SG, Taly AB, Nagarajan K, Jayakumar PN, Patil S. Clinicoradiological features of tuberculous meningitis in patients over 50 years of age. J Neurol Neurosurg Psychiatry 2007;78:536-8.
29. Morgado C, Ruivo N. Imaging meningo-encephalic tuberculosis. EurJ Radiol 2005;55:188-92.
30. van Loenhout-Rooyackers JH, Keyser A, Laheij RJ, Verbeek AL, van der Meer JW. Tuberculous meningitis: Is a 6-month treatment regimen sufficient? Int J Tuberc Lung Dis 2001;5:128-35.
31. World Health Organization. Multidrug and extensively drugresistant TB (M/XDR-TB): 2010 global report on surveillance and response, 2010.
32. Zager EM, McNerney R. Multidrug-resistant tuberculosis. BMC Infect Dis 2008;8:10.
33. Patel VB, Padayatchi N, Bhigjee AI, Allen J, Bhagwan B, Moodley AA, et al. Multidrug-resistant tuberculous meningitis in Kwazulu-Natal, South Africa. Clin Infect Dis 2004;38:851-6.
34. Daikos GL, Cleary T, Rodriguez A, Fischl MA. Multidrug-resistant tuberculous meningitis in patients with AIDS. Int J Tuberc Lung Dis 2003;7:394-8.
35. Thwaites GE, Lan NT, Dung NH, Quy HT, Oanh DT, Thoa NT, et al. Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitis. J Infect Dis 2005;192:79-88.
36. Matteelli A, Migliori GB, Cirillo D, Centis R, Girard E, Raviglion M. Multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis: Epidemiology and control. Expert Rev Anti Infect Ther 2007;5:857-71.
37. Andries K, Verhasselt P, Guillemont J, Göhlmann HW, Neefs JM, Winkler H, et al. A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 2005;307:223-7.
38. Koul A, Dendouga N, Vergauwen K, Molenberghs B, Vranckx L, Willebrords R, et al. Diarylquinolines target subunit c of mycobacterial ATP synthase. Nat Chem Biol 2007;3:323-4.
39. Huitric E, Verhasselt P, Andries K, Hoffner SE. In vitro antimycobacterial spectrum of a diarylquinoline ATP synthase inhibitor. Antimicrob Agents Chemother 2007;51:4202-4.
40. Koul A, Vranckx L, Dendouga N, Balemans W, Van den Wyngaert I, Vergauwen K, et al. Diarylquinolines are bactericidal for dormant mycobacteria as a result of disturbed ATP homeostasis. J Biol Chem 2008;283:273-80.
41. Diacon AH, Pym A, Grobusch M, Patientia R, Rustomjee R, Page- Shipp L, et al. The diarylquinoline TMC207 for multidrug-resistant tuberculosis. N Engl J Med 2009;360:2397-405.
42. Prasad K, Singh MB. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev 2008;1:CD002244.
43. Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med 2004;351:1741-51.
44. Greisman LA, Mackowiak PA. Fever: Beneficial and detrimental effects of antipyretic. Curr Opin Infect Dis 2002;15:241-5.
45. Axelrod YK, Diringer MN. Temperature management in acute neurologic disorders. Crit Care Clin 2007;22:767-85
46. Wass CT, Lanier WL, Hofer RE, Scheithauer BW, Andrews AG. Temperature changes of > or = 1degree C alter functional neurologic outcome and histopathology in canine model of complete cerebral ischemia. Anesthesiology 1995;83:325-35.
47. Cairns CJ, Andrews PJ. Management of hyperthermia in traumatic brain injury. Curr Opin Crit Care 2002;8:106-60.
48. Rossi S, Roncati Zanier E, Mauri I, Columbo A, Stocchetti N. Brain temperature, body core temperature, and intracranial pressure in acute cerebral damage. J Neurol Neurosurg Pscybiatry 2001;71:448-54.
49. Bryant RE, Hood AF, Hood CE, Koenig MG. Factors affecting mortality of gram-negative rod bacteremia. Arch Intern Med 1971;127:120-8.
50. Christopher R, Gourie-Devi M. The syndrome of inappropriate antidiuretic hormone secretion in tuberculous meningitis. J Assoc Phys Ind 1997;45:933-5.
51. Singh BS, Patwari AK, Deb M. Serum sodium and osmolal changes in tuberculous meningitis. Indian Pediatr 1994;31:1345-50.
52. Narotam PK, Kemp M, Buck R, Gouws E, van Dellen JR, Bhoola KD. Hyponatremic natriuretic syndrome in tuberculous meningitis: The probable role of arterial natriutetic peptide. Neurosurgery 1994;34:982-8.
53. Gujjar AR. Sodium dysregulation and infections of central nervous system. Ann Ind Acad Neurol 2003;6:253-8.
54. Celik US, Alabaz D, Yildizdas D, Alhan E, Kocabas E, Ulutan S. Cerebral salt wasting in tuberculous meningitis: Treatment with fludrocortisone. Ann Trop Paediatr 2005;25:297-302.
55. Ti LK, Kang SC, Cheong KF. Acute hyponatraemia secondary to cerebral salt wasting syndrome in a patient with tuberculous meningitis. Anaesth Intensive Care 1998;26:420-3.
56. Ravishankar B, Mangala, Prakash GK, Shetty KJ, Ballal HS. Cerebral salt wasting syndrome in a patient with tuberculous meningitis. J Assoc Physicians India 2006;54:403-4.
57. Huang SM, Chen CC, Chiu PC, Cheng MF, Chiu CL, Hsieh KS. Tuberculous meningitis complicated with hydrocephalus and cerebral salt wasting syndrome in a three-year-old boy. Pediatr Infect Dis J 2004;23:884-6.
58. Das R, Nagaraj R, Murlidharan J, Singhi S. Hyponatraemia and hypovolemic shock with tuberculous meningitis. Indian J Pediatr 2003;70:995-7.
59. Loo KL, Ramachandran R, Abdullah BJ, Chow SK, Goh EM, Yeap SS. Cerebral infarction and cerebral salt wasting syndrome in a patient with tuberculous meningoencephalitis. Southeast Asian J Trop Med Public Health 2003;34:636-40.
60. Harrigan MR. Cerebral salt wasting syndrome. Crit Care Clin 2001;17:125-38.
61. Kroll M, Juhler M, Lindholm J. Hyponatremia in acute brain disease. J Intern Med 1992;232:291-7.
62. Sarkarcan A, Boochini J Jr. Rhe role of fludrocortisone in a child with cerebral salt wasting. Pediatr Nephrol 1998;12:769-71.
63. Camous L, Valin N, Zaragoza JL, Caumes E, Deray G, Izzedine H. Hyponatremic syndrome in a patient with tuberculosis - always the adrenals? Nephrol Dial Transplant 2008;23:393-5.
64. Murthy JM, Jayalaxmi SS, Kanikannan MA. Convulsive status epilepticus: Clinical profile in a developing country. Epilepsia 2007;48:2217-23.
65. Narayanan JT, Murthy JM. Nonconvulsive status epilepticus in a neurological intensive care unit: Profile in a developing country. Epilepsia 2007;48:900-6.
66. Narayanan JT, Murthy JM. New onset acute symptomatic seizures in neurological intensive care unit. Neurol India 2007;55:136-40.
67. Patel NC, Landan IR, Levin J, Szaflarski J, Wilner AN. The use of levetiracetam in refractory status epilepticus. Seizure 2006;15:137-41.
68. Rupprecht S, Franke K, Fitzek S, Witte OW, Hagemann G. Levetiracetam as a treatment option in non-convulsive status epilepticus. Epilepsy Res 2007;73:238-44.
69. Rossetti AO, Bromfield EB. Determinants of success in the use of oral levetiracetam in status epilepticus. Epilepsy Behav 2006;8:651-4.
70. Murthy JM. Acute symptomatic seizures: Clinical and etiological spectrum in developing countries. In: Murthy JM, Senanayake N, editors. Epilepsy in tropics. Georgetown: Landes Bioscience; 2006. p. 133-43.
71. Patsalos PN, Perucca E. Clinically important drug interactions in epilepsy: Interactions between antiepileptic drugs and other drugs. Lancet Neruol 2003;2:473-81.
72. Miller RR, Porter J, Greebblatt DJ. Clinical importance of the interaction of phenytoin and isoniazid: A report from the Boston Collaborative Drug Surveillance Program. Chest 1979;75:353-8.
73. Dastur DK, Manghani DK, Udani PM. Pathology and pathogenetic mechanisms in neurotuberculosis. Radiol Clin North Am 1995;33:733-52.
74. Shankar SK, Santosh V, Mahadevan A, Yasha TC, Satishchandra P. Pahtology of cerebral vasculature in neurotuberculosis-some observations. In: Mehata VS, Misra UK, editors. Progress in Neurosciences. New Delhi: Neurological Society of India; 2003.p.134-41.
75. Mathew NT, Abraham J, Chandy J. Cerebral angiographic features in tuberculous meningitis. Neurology 1970;20:1015-23.
76. Schoeman JF, Elshof JW, Laubscher JA, Janse van Rensburg A, Donald PR. The effect of adjuvant steroid treatment on serial cerebrospinal fluid changes in tuberculous meningitis. Ann Trop Paediatr 2000;21:299-305.
77. van der Flier M, Hoppenreijs S, van Rensburg AJ, Ruyken M, Kolk AH, Springer P, et al. Vascular endothelial growth factor and bloodbrain barrier distruption in tuberculous meningitis. Pediatr Infect Dis J 2004;23:608-13.
78. Gujjar AR, Srikanth SG, Umamaheshwara Rao GS. HHH regime forarteritis secondary to TB meningitis: A prospective randomized study. Neurocrit Care 2009;10:313-7.
79. Singh D, Kumar S. Ventriculoperitoneal shunt in post tubercular hydrocephalus. Indian Pediatr 1996;33:854-5.
80. Mathew JM, Rajshekhar V, Chandy MJ. Shunt surgery for poor grade patients with tuberculous meningitis and hydrocephalus: Effect of response to external ventricular drainage and other factors on long-termoutcome. J Neurol Neurosurg Psychiatry 1998;65:115-8.
81. Agrawal D, Gupta A, Mehta VS. Role of shunt surgery in pediatric tubercular meningitis with hydrocephalus. Indian Pediatrics 2005;42:245-50.
82. Sil K, Chatterjee S. Shunting in tuberculous meningitis: A neurosurgeon's nightmare. Childs Nerv Syst 2008;24:1029-32.
83. Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med 2000;342:1681-9.
84. Flores-Cordero JM, Amaya-Villar R, Rincón-Ferrari MD, Leal- Noval SR, Garnacho-Montero J, Llanos-Rodríguez AC, et al. Acute community-acquired bacterial meningitis in adults admitted to the intensive care unit: Clinical manifestations, management and prognostic factors. Intensive Care Med 2003;29:1967-73.
85. Gliemroth J, Bahlmann L, Klaus S, Klöhn A, Arnold H. Long-time microdialysis in a patient with meningoencephalitis. Clin Neurol Neurosurg 2002;105:27-31.
86. Shetty R, Singhi S, Singhi P, Jayashree M. Cerebral perusion pressuretargeted approach in children with central nervous system infections and raised intracranial pressure: Is it feasible? J Child Neurol 2008;23:192-8.
87. Lindvall P, Ahlm C, Ericsson M, Gothefors L, Naredi S, Koskinen LO. Reducing intracranial pressure may increase survival among patients with bacterial meningitis. Clin Infect Dis 2004;38:384-90.
88. Himmelseher S. Hypertonic saline solutions for treatment of intracranial hypertension. Curr Opin Anaesthesiol 2007;20:414-26.
89. Schoeman J, Donald P, van Zyl L, Keet M, Wait J. Tuberculous hydrocephalus: Comparison of different treatments with regard to ICP, ventricular size and clinical outcome. Dev Med Child Neurol 1991;33:396-405.
90. Lamprecht D, Schoeman J, Donald P, Har tzenberg H. Ventriculoperitoneal shunting in childhood tuberculous meningitis. Br J Neurosurg 2001;15:119-25.
91. Kemaloglu S, Ozkan U, Bukte Y, Ceviz A, Ozates M. Timing of shunt surgery in childhood tuberculous meningitis with hydrocephalus. Pediatr Neurosurg 2002;37:194-8.
92. Girgis NI, Sultan Y, Farid Z, Mansour MM, Erian MW, Hanna LS, et al. Tuberculosis meningitis, Abbassia Fever Hospital-Naval Medical Research Unit No. 3-Cairo, Egypt from 1976 to 1996. Am J Trop Med Hyg 1998;58:28-34.